Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>PI3K / Akt / mTOR>S6 Kinase Inhibitors>LY-2584702 free base
LY-2584702 free base
  • LY-2584702 free base

LY-2584702 free base NEW

Price $116 $150 $332
Package 5mg 10mg 25mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-12-04

Product Details

Product Name: LY-2584702 free base CAS No.: 1082949-67-4
Purity: 99.51% Supply Ability: 10g
Release date: 2025/12/04

Product Introduction

Bioactivity

NameLY-2584702 free base
DescriptionLY2584702 is a selective, ATP-competitive p70S6K inhibitor(IC50: 4 nM).
In vitroIn HCT116 colon cancer cells, LY2584702 inhibits phosphorylation of the S6 ribosomal protein (pS6) with IC50 of 0.1-0.24 μM[1]. Combined with EGFR inhibitor erlotinib or with the mTOR inhibitor everolimus, LY2584702 has significant synergistic effects [2].
In vivoLY2584702 (12.5 mg/kg BID), shows significant antitumor activity in both U87MG glioblastoma and HCT116 colon carcinoma xenograft models. [1]
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : 1 mg/mL (2.25 mM), Heating is recommended.
KeywordsS6Kinase | S6K | S6 Kinase | Ribosomal S6 Kinase (RSK) | mTOR (p70S6K) | LY-2584702 free base | LY2584702 free base | LY-2584702 | LY2584702 | LY 2584702 free base | LY 2584702 | Inhibitor | inhibit
Inhibitors RelatedStearamide | 4-Vinylcyclohexene Dioxide | Sapanisertib | N-Hydroxyphthalimide | L-Proline | Methyl eugenol | Metformin hydrochloride | RMC-7977 | Dihydromyricetin | Acesulfame Potassium | Sodium salicylate | NMac1
Related Compound LibrariesBioactive Compound Library | Pain-Related Compound Library | Kinase Inhibitor Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Fibrosis Compound Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$1980.00/50mg
VIP2Y
TargetMol Chemicals Inc.
2025-10-27
$0.00/25KG
VIP2Y
Shaanxi Dideu New Materials Co. Ltd
2025-05-16

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY